Back to Results
First PageMeta Content
Clinical research / Science / Food and Drug Administration / Design of experiments / Medical statistics / Institutional review board / Clinical trial / Form FDA 483 / Pharmacology / Research / Health


FDA Warning Letter to Texas Applied Biomedical Services (TABS IRB[removed]
Add to Reading List

Document Date: 2012-10-16 14:13:54


Open Document

File Size: 138,67 KB

Share Result on Facebook

City

Rockville / /

Company

Texas Applied Biotechnology Research Review Committee IRB / TABS RRC / J Heinrich Consulting / TABS Inc. / /

Event

FDA Phase / /

Facility

Rockville Pike / /

IndustryTerm

clinical study protocols / /

MedicalCondition

subjects’ disorder / deficiency / disorders / /

Organization

Food and Drug Administration Center for Biologics Evaluation and Research / Compliance and Biologics Quality Center for Biologics Evaluation and Research / Institutional Review Board / FDA District Office / Food and Drug Administration / office of Compliance / TABS Research Review Committee / Biologics Quality Center for Biologics Evaluation and Research Page Last Updated / Lillian Ortega Division of Inspections and Surveillance / Department of Health and Human Services / Texas Applied Biomedical Services Research Review Committee / /

Person

Mildred Joyce / Mary A. Malarkey / Heinrich / Lillian Ortega / /

/

Position

investigator / President /Chairperson Texas Applied Biomedical Services / recording secretary / president / Director / physician / Chairperson / independent consultant / representative / medical advisors / /

Product

FDA / /

ProvinceOrState

Texas / Maryland / /

Technology

clinical study protocols / Biotechnology / /

URL

http /

SocialTag